Leukotriene B4 receptor 2 correlates with prognosis and immune infiltration in clear cell renal cell carcinoma
Conclusion. BLT2 may serve as a novel prognostic biomarker and is related to the shaping of tumor immune microenvironment in ccRCC. The expression of BLT2 potentially contributes to the regulation of TAMs, T cell exhaustion, and Tregs activation in ccRCC, providing new approaches to promote the development of new immunotherapeutic strategies for ccRCC.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Databases & Libraries | Drugs & Pharmacology | Genetics | Investigational New Drugs | Kidney Cancer | Renal Cell Carcinoma | Study